(Q35784255)

10 August 2017

1 reference

title

Immunogenicity and protective efficacy of influenza vaccination (English)

1 reference

10 August 2017

Claude Hannoun

1

1 reference

PubMed ID

15163501

10 August 2017

Francoise Megas

series ordinal

2

1 reference

PubMed ID

15163501

10 August 2017

James Piercy

series ordinal

3

1 reference

10 August 2017

1 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

103

1 reference

10 August 2017

133-138

1 reference

10 August 2017

1-2

1 reference

Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic.

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Immune response to influenza vaccination in a large healthy elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Antibody induction by influenza vaccines in the elderly: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Humoral immune response to influenza vaccination in patients from high risk groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Epidemiologic methods in immunization programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Influenza: prospects for control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Immunity to influenza in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Improvement of inactivated influenza virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Prevention and early treatment of influenza in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Inactivated influenza vaccines. 2. Laboratory indices of protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Association of influenza immunization with reduction in mortality in an elderly population. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Influenza in children with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Failure of influenza vaccination in the aged

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

French economic evaluations of influenza and influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Influenza vaccines. A reappraisal of their use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Determinants of immunity to influenza infection in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Pandemic versus epidemic influenza mortality: a pattern of changing age distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

The impact of influenza epidemics on mortality: introducing a severity index.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

The impact of influenza epidemics on hospitalizations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

The socio-economic burden of influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

[Public health costs of influenza in Germany 1996- a cost-of-illness analysis]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2004.02.025

1 reference

10 August 2017

1 reference

PubMed ID

15163501